Compare a breast imaging scan with MRI in high-risk women
Part of Cancer, Skin clinical trials.
This study compares two ways of imaging the breast—molecular breast imaging (a scan that uses a small radioactive tracer) and standard breast MRI—to better find or rule out breast cancer. You may join if you are considered high risk and already have a breast MRI planned, and you can do both tests close together.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman age 18 or older with a high lifetime risk of breast cancer
- Your high risk may be based on risk calculations, certain precancer changes, or a breast-cancer gene mutation
- You are scheduled for a breast MRI and can complete both MRI and MBI within about two weeks
- If either test finds something concerning, you are willing to have a biopsy and provide follow-up answers after the tests
- You must be able to give written consent (and an interpreter can help if you don’t speak English)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing whether adding an MRI to your regular mammogram can help find any new breast cancers earlier. It is for women who have had breast cancer before and still have dense breast tissue, making mammograms harder to read.
This study uses a breast MRI scan to look at suspicious areas in the breast. It may help doctors better tell which breast changes need closer follow-up like a biopsy.
This study is testing whether adding an MRI to a normal mammogram can find more cancers in women with dense breasts. If you participate, you may benefit from extra monitoring and peace of mind.
This trial compares a special mammogram with dye (CEDM) to MRI for women already diagnosed with invasive breast cancer. The goal is to see if CEDM works as well as MRI for planning surgery, potentially offering a faster or easier option.
This study tests whether a special type of mammogram, called contrast-enhanced mammography (CEM), can better spot additional breast abnormalities that were seen on your MRI. It might help doctors decide on the best next steps without needing more invasive tests.
This study tests selected treatment decisions for women with early-stage breast cancer that has certain lab test results. It may help researchers better match care using MRI and tumor marker information.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.